Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

MammoSite Radiation Therapy System (RTS) as the Sole Radiation Therapy Technique for Ductal Carcinoma In-Situ (DCIS)

NCT00586326 is registered in ClinicalTrials.gov with Hologic, Inc. as lead sponsor.

NCT NCT00586326
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00586326 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
MammoSite Radiation Therapy System (RTS) as the Sole Radiation Therapy Technique for Ductal Carcinoma In-Situ (DCIS)
Lead sponsor
Hologic, Inc.
Phase
Phase 2
Overall status
Completed
Start date
August 31, 2003
Completion date
April 30, 2011
Enrollment
133 (actual)
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

dcis